comparemela.com

Latest Breaking News On - Emyria data - Page 1 : comparemela.com

Emyria Ltd capitalises on Cann Group Ltd collaboration to progress EMD-003 CBD medicine for mental health

Deep Dive - Emyria Ltd

Emyria Ltd begins recruiting for EMD-RX5 Phase 1 clinical safety and bioavailability study

Emyria Ltd (ASX:EMD) has started participant recruitment, screening and consenting for its Phase 1 clinical trial of EMD-RX5, with dosing expected to begin.

vimarsana © 2020. All Rights Reserved.